Advertisement
Review Article| Volume 31, ISSUE 1, P71-83, March 2023

Botulinum Toxin in Facial Reanimation

Map of the Facial Musculature and Dosage
  • Tracy VandeWater
    Affiliations
    Department of Otolaryngology–Head & Neck Surgery, Louisiana State University Health Sciences Center, 533 Bolivar Street, Suite 566, New Orleans, LA 70112, USA
    Search for articles by this author
  • Laura Hetzler
    Correspondence
    Corresponding author.
    Affiliations
    Department of Otolaryngology–Head & Neck Surgery, Louisiana State University Health Sciences Center, 533 Bolivar Street, Suite 566, New Orleans, LA 70112, USA

    Center For Facial Nerve Disorders, Our Lady of The Lake Regional Medical Center, 4950 Essen Lane, Suite 402, Baton Rouge, LA 70809, USA
    Search for articles by this author
DOI:https://doi.org/10.1016/j.cxom.2022.09.007
Botulinum Toxin in Facial Reanimation
Previous ArticleModified Selective Neurectomy for Post Facial Paralysis Synkinesis Smile Dysfunction

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Atlas of the Oral and Maxillofacial Surgery Clinics of North America
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      Recommended reading

        • Azizzadeh B.
        • Frisenda J.L.
        Surgical management of postparalysis facial palsy and synkinesis.
        Otolaryngol Clin North Am. 2018; 51: 1169-1178
        • Bellows S.
        • Jankovic J.
        Immunogenicity associated with botulinum toxin treatment.
        Toxins (Basel). 2019; 11: 491
        • Borodic G.E.
        • Pearce L.B.
        • Cheney M.
        • et al.
        Botulinum A toxin for treatment of aberrant facial nerve regeneration.
        Plast Reconstr Surg. 1993; 91: 1042-1045
        • Bran G.M.
        • Lohuis P.J.
        Selective neurolysis in post-paralytic facial nerve syndrome (PFS).
        Aesthetic Plast Surg. 2014; 38: 742-744
        • Celik M.
        • Forta H.
        • Vural C.
        The development of synkinesis after facial nerve paralysis.
        Eur Neurol. 2000; 43: 147-151
        • Derakhshan A.
        • Miller M.Q.
        • Malka R.
        • et al.
        Releasing the smile: depressor anguli oris excision in the context of managing nonflaccid facial palsy.
        Plast Reconstr Surg. 2022; 149: 261e-269e

      7. Field Malgorzata, et al., AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients, Toxins, 2018.

        • Filipo R.
        • Spahiu I.
        • Covelli E.
        • et al.
        Botulinum toxin in the treatment of facial synkinesis and hyperkinesis.
        Laryngoscope. 2012; 122: 266-270
        • Hetzler L.T.
        • Hershey M.
        • Lambert T.
        • et al.
        Anatomic considerations of perinasal musculature for improved dental show during smile in facial synkinesis.
        Facial Plast Surg Aesthet Med. 2022; 24: 89-94
        • Husseman J.
        • Mehta R.P.
        Management of synkinesis.
        Facial Plast Surg. 2008; 24: 242-249
        • Jowett N.
        • Hadlock T.A.
        A contemporary approach to facial reanimation.
        JAMA Facial Plast Surg. 2015; 17 ([Erratum in: JAMA Facial Plast Surg. 2015 Sep-Oct;17(5):386. PMID: 26042960]): 293-300
        • Jowett N.
        • Hadlock T.A.
        An evidence-based approach to facial reanimation.
        Facial Plast Surg Clin North Am. 2015; 23: 313-334
        • Klein A.W.
        Contraindications and complications with the use of botulinum toxin.
        Clin Dermatol. 2004; 22: 66-75
        • Leader B.
        • Azizzadeh B.
        Synkinetic unilateral lower lip palsy: diagnosis and technical considerations for facial reanimation.
        Facial Plast Surg Aesthet Med. 2021; 23: 309-311
        • Masuoka H.
        The visualization of the functional role of the depressor septi nasi muscle by ultrasound.
        Plast Reconstr Surg Glob Open. 2017; 5: e1406
        • Moran C.J.
        • Neely J.G.
        Patterns of facial nerve synkinesis.
        Laryngoscope. 1996; 106: 1491-1496
        • Shokri T.
        • Patel S.
        • Ziai K.
        • et al.
        Facial synkinesis: a distressing sequela of facial palsy.
        Ear Nose Throat J. 2021; (1455613211054627)https://doi.org/10.1177/01455613211054627

      Article info

      Footnotes

      Financial Disclosures or Conflicts of Interest: None.

      Identification

      DOI: https://doi.org/10.1016/j.cxom.2022.09.007

      Copyright

      Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX